Characterization of human stem cells and therapeutic strategies involving IGF-1 and shRNA in Huntington's disease
Year: 2015
Type: dissertation
Abstract: Huntington's disease (HD) is an autosomal dominant disease caused by an expansion of CAG repeats in the gene encoding for huntingtin (HTT) and characterized by motor, cognitive and psychiatric symptoms. Despite HD monogenic etiology, its pathogenesis is incredibly complex and several mechanisms of neuronal dysfunction have been proposed. Given the diversity of mutant HTT interactions and the fact that there is still no cure or neuroprotective treatment for HD, in this study we aimed to clarify the early pathological mechanisms involving deficits in energy metabolism linked to mitochondrial dysfunction, altered cell cycle and modified signaling pathways, as well as evaluate the influence of treatment approaches targeting distinct cellular mechanisms in vitro and in vivo. In the first part of this work we investigated the pathological mechanisms that have been proposed for neurodegeneration, including mitochondrial dysfunction and oxidative stress in HD patient-specific induced pluripotent stem cells (HD-iPSC) and derived HD-NSC versus cells expressing normal HTT. We showed that HD-iPSCs possessed hyperpolarized mitochondria and reduced mitochondrial Ca2+ storage capacity. HD-iPSCs mitochondria exhibited round shape morphology, but no differences in fission/fusion proteins were found. HD-iPSCs also consumed less O2, exhibited decreased complex I+III activities and had lower ATP/ADP ratio, which was in accordance with the observation that HD cells relied more on glycolysis. Moreover, HD-iPSCs showed increased phosphorylation of pyruvate dehydrogenase (PDH) subunit E1α at Ser 232, 293 and 300, reflecting its inactivation. Concordantly, increased levels of pyruvate dehydrogenase kinase, isozyme 1 (PDK1) were found. In addition, increased levels of mitochondrial superoxide anion and hydrogen peroxide were observed in HD-iPSCs. These results were consistent with increased acetylation and decreased activity of superoxide dismutase 2 (SOD2) in HD cells. Our study suggests that human HD-iPSC can help to reveal the role of mitochondrial and metabolic dysfunction in early stages of HD. In the second part of the work we analysed the role of HTT in the control of mitosis, namely whether it has an important impact on asymmetric division and cell fate. Using human embryonic stem cells (hESC) characterized as adult-onset mutant gene carriers, we qualified the role of human HTT in mitotic spindle orientation in human neural stem cells (derived from the hESC) and the effect of the adult-onset HD mutation. RNAi-mediated silencing of HTT in neural stem cells derived from wild type hESC disrupted spindle orientation and mislocalized dynein, the P150Glued subunit of dynactin and the large nuclear mitotic apparatus NUMA protein. We further addressed the effect of an adult-onset HD mutation on spindle orientation in neural cells derived from HD-specific hESC. After identifying single-nucleotide polymorphism (SNP) we combined SNP-targeting allele-specific silencing and gain of function approaches, showing that expression of human HTT with 46 glutamines was sufficient to induce a dominant negative effect on spindle orientation and alteration of the localization of dynein, P150Glued and NUMA in neural stem cells. These findings revealed that neural derivatives of disease-specific human pluripotent stem cells constitute a relevant biological resource for exploring the impacts of adult onset HTT mutations on neural progenitors division with potential application in HD drug discovery targeting HTT-dynein- P150Glued complex functions. Following the previous data from in vitro studies showing that Akt has a beneficial role on HD phenotype, in the third part of the work, we detailed the changes in an animal model of the disease and treatment response to IGF-1. Thus, we analysed brain metabolic dysfunction and altered Akt signaling and the protective role of insulin-like growth factor-1 (IGF-1)/Akt pathway in HD. We investigated motor phenotype, peripheral and central metabolic profile, and striatal and cortical signaling pathways in HD transgenic YAC128 mice subjected to intranasal administration of recombinant human IGF-1 (rhIGF-1), in order to promote IGF-1 delivery to the brain. IGF-1 supplementation enhanced IGF-1 cortical levels and improved motor activity and both peripheral and central metabolic abnormalities in YAC128 mice. Moreover, decreased Akt activation in HD mice brain was ameliorated following IGF-1 administration. Upregulation of Akt following rhIGF-1 treatment occurred concomitantly with increased phosphorylation of mutant HTT at Ser421. These data suggested that intranasal administration of rhIGF-1 ameliorates HD-associated glucose metabolic brain abnormalities and mice phenotype. The present work enlightens the mechanisms underlying mitochondrial dysfunction and metabolic impairment as well as the role of HTT in cell cycle and cell fate occurring in early stages of HD. Moreover, we exploit therapeutic approaches targeting different molecular pathways, which were efficient per se in delaying disease phenotype, namely the selective inhibition of mutant HTT translation using shRNA in HD-patient’s derived neural stem cells and the activation of brain intracellular signaling pathways induced by IGF-1 in an animal model of HD. These studies provide new insights into HD pathogenesis which, hopefully, may result in improved therapeutic approaches for the disease.
Author: Carla Lopes
Institution: University of Coimbra
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Huntington's disease, induced pluripotent stem cells, human embryonic stem cells, neural stem cells, mitochondrial dysfunction, oxidative stress, pyruvate dehydrogenase, PDK1, manganese superoxide dismutase, glycolysis, mitotic spindle orientation, asymmetric cell division, cell cycle, insulin-like growth factor I, shRNA, huntingtin, neurodegeneration, energy metabolism
Open Access status: green
Award: G1578237752
OpenAlex ID: W2509713858
